DNA damage repair (DDR) gene mutations (mut) are predictors of response to platinum-based chemotherapy in advanced pancreatic cancer (PC) patients (pts)

被引：0
|
作者：
Verdaguer, H. [1 ]
Guardiola, M. [2 ]
Mancuso, F. M. [3 ]
Acosta Eyzaguirre, D. A. [4 ]
Buxo, E. [1 ]
Hernando, J. [5 ]
Diez Garcia, M. [4 ]
Laquente, B. [6 ]
Baraibar Argota, I. [7 ]
Ros Montana, F. J. [8 ]
Garcia-Alvarez, A. [4 ]
Matito, J. [3 ]
Martin, A. [3 ]
Sierra, A. [9 ]
Villacampa Javierre, G. [10 ]
Molero, C. [11 ]
Miquel, J. M. [11 ]
Vivancos, A. [12 ]
Dienstmann, R. [13 ]
Macarulla Mercade, T. [14 ]
机构：
[1] Vall dHebron Univ Hosp, Inst Oncol, Med Onol, Barcelona, Spain
[2] Vall dHebron Univ Hosp, Inst Oncol, Oncol Data Sci, Barcelona, Spain
[3] Vall dHebron Inst Oncol VHIO, Canc Genom, Barcelona, Spain
[4] Vall dHebron Univ Hosp, Med Oncol Dept, Barcelona, Spain
[5] Vall Hebron Univ Hosp, Vall Hebron Inst Oncol VHIO, Med Oncol Dept, Barcelona, Spain
[6] Hosp Duran & Reynals, ICO Inst Catala Oncol, Med Oncol Dept, Lhospitalet De Llobregat, Spain
[7] Vall dHebron Univ Hosp, Med Oncol, Barcelona, Spain
[8] Vall dHebron Univ Hosp, Oncol, Barcelona, Spain
[9] VHIO, Prescreening Program, Barcelona, Spain
[10] Vall dHebron Inst Oncol VHIO, Stat Dept, Barcelona, Spain
[11] Vall dHebron Inst Oncol VHIO, Project Managment, Barcelona, Spain
[12] Vall dHebron Univ Hosp, Genom, Barcelona, Spain
[13] Vall dHebron Univ Hosp, Oncol Data Sci, Barcelona, Spain
[14] DHebron Univ Hosp HUVH, Med Oncol, Barcelona, Spain
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.2028
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1545P
引用
收藏
页码：S947 / S947
页数：1
相关论文
共 50 条
  • [21] Platinum-based chemotherapy in metastatic prostate cancer with alterations in DNA damage repair genes.
    Mota, Jose Mauricio
    Barnett, Ethan
    Nauseef, Jones
    Stopsack, Konrad Hermann
    Wibmer, Andreas Georg
    Danila, Daniel Costin
    Rathkopf, Dana E.
    Slovin, Susan F.
    Kantoff, Philip W.
    Scher, Howard I.
    Morris, Michael J.
    Solit, David B.
    Abida, Wassim
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [22] Platinum-based chemotherapy for pancreatic cancer: impact of mutations in the homologous recombination repair and Fanconi anemia genes
    Emelyanova, Marina
    Pudova, Elena
    Khomich, Darya
    Krasnov, George
    Popova, Anna
    Abramov, Ivan
    Mikhailovich, Vladimir
    Filipenko, Maxim
    Menshikova, Sofia
    Tjulandin, Sergey
    Pokataev, Ilya
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [23] Retrospective analysis of type of KRAS mutation (mut) and response to first-line platinum-based chemotherapy (PC) in non-small cell lung cancer (NSCLC) patients (pts)
    Mellema, Wouter Willem
    Masen-Poos, Lucie
    Hendriks, Lizza
    Van Der Wekken, Anthonie
    Aerts, Joachim
    Herder, Judith
    Stigt, Jos
    Van den Borne, Ben
    van den Heuvel, Michel M.
    Pouw, Ellen
    Dingemans, Anne-Marie C.
    Smit, Egbert F.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [24] Effect of eIF3a on Response of Lung Cancer Patients to Platinum-Based Chemotherapy by Regulating DNA Repair
    Yin, Ji-Ye
    Shen, Jie
    Dong, Zi-Zheng
    Huang, Qiong
    Zhong, Mei-Zuo
    Feng, De-Yun
    Zhou, Hong-Hao
    Zhang, Jian-Ting
    Liu, Zhao-Qian
    CLINICAL CANCER RESEARCH, 2011, 17 (13) : 4600 - 4609
  • [25] Association of DNA Repair Gene Polymorphisms With Response to Platinum-Based Doublet Chemotherapy in Patients With Non-Small-Cell Lung Cancer
    Shiraishi, Kouya
    Kohno, Takashi
    Tanai, Chiharu
    Goto, Yasushi
    Kuchiba, Aya
    Yamamoto, Seiichiro
    Tsuta, Koji
    Nokihara, Hiroshi
    Yamamoto, Noboru
    Sekine, Ikuo
    Ohe, Yuichiro
    Tamura, Tomohide
    Yokota, Jun
    Kunitoh, Hideo
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (33) : 4945 - 4952
  • [26] Concordance of DNA damage repair (DDR) gene mutations in paired primary and metastatic prostate cancer (PC) samples.
    Schweizer, Michael Thomas
    Sivakumar, Smruthy
    Tukachinsky, Hanna
    Coleman, Ilsa
    De Sarkar, Navonil
    Yu, Evan Y.
    Konnick, Eric Quentin
    Nelson, Peter
    Pritchard, Colin C.
    Montgomery, Robert B.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [27] Maintenance Therapy for ATM-Deficient Pancreatic Cancer by Multiple DNA Damage Response Interferences after Platinum-Based Chemotherapy
    Roger, Elodie
    Gout, Johann
    Arnold, Frank
    Beutel, Alica K.
    Mueller, Martin
    Abaei, Alireza
    Barth, Thomas F. E.
    Rasche, Volker
    Seufferlein, Thomas
    Perkhofer, Lukas
    Kleger, Alexander
    CELLS, 2020, 9 (09)
  • [28] Role of different germline BRCA mutations in response to platinum-based chemotherapy in patients (pts) with triple-negative breast cancer (TNBC).
    Frolova, Mona
    Ignatova, Ekaterina
    Stenina, Marina B.
    Petrovsky, Alexander
    Tjulandin, Sergei
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [29] DNA Damage Response (DDR) Gene Mutations and Correlation With Immunotherapy Response in NSCLC Patients
    Liu, J.
    Zhou, H.
    Ma, W.
    Zhang, Y.
    Zhou, T.
    Yang, Y.
    Huang, J.
    Zhao, Y.
    Hong, S.
    Zhan, J.
    Zhao, H.
    Huang, Y.
    Fang, W.
    Zhang, L.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S893 - S894
  • [30] DNA Repair Gene Associated with Clinical Outcome of Epithelial Ovarian Cancer Treated with Platinum-based Chemotherapy
    Kang, Shan
    Sun, Hai-Yan
    Zhou, Rong-Miao
    Wang, Na
    Hu, Pei
    Li, Yan
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (02) : 941 - 946
12345